Mustang Net Working Capital from 2010 to 2024

MBIO Stock  USD 0.20  0.01  5.26%   
Mustang Bio Net Working Capital yearly trend continues to be very stable with very little volatility. Net Working Capital is likely to grow to about -3.8 M this year. During the period from 2010 to 2024, Mustang Bio Net Working Capital quarterly data regression pattern had sample variance of 785.5 T and median of  57,750,000. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
-4 M
Current Value
-3.8 M
Quarterly Volatility
28 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Latest Mustang Bio's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Mustang Bio over the last few years. It is Mustang Bio's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Mustang Net Working Capital Regression Statistics

Arithmetic Mean52,906,950
Geometric Mean41,399,284
Coefficient Of Variation52.98
Mean Deviation18,274,880
Median57,750,000
Standard Deviation28,027,605
Sample Variance785.5T
Range104.9M
R-Value(0.31)
Mean Square Error767.2T
R-Squared0.09
Significance0.27
Slope(1,912,458)
Total Sum of Squares10997.7T

Mustang Net Working Capital History

2024-3.8 M
2023-4 M
202263.7 M
2021100.9 M
202090 M
201955.3 M
201829.5 M

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as Net Working Capital, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Working Capital-4 M-3.8 M

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Mustang Stock

  0.51WAT WatersPairCorr
  0.43BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.37BHC Bausch Health CompaniesPairCorr
  0.32VTRS ViatrisPairCorr
  0.32ESPR Esperion Therapeutics Buyout TrendPairCorr
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.33)
Revenue Per Share
(0)
Return On Assets
(0.97)
Return On Equity
(11.91)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.